首页> 外国专利> POTENTIATION OF THE THERAPEUTIC ACTION OF AN OPIOID RECEPTOR AGONIST AND/OR INHIBITION OR REVERSAL OF TOLERANCE TO OPIOID RECEPTOR AGONISTS USING AN ULTRALOW DOSE OF AN ALPHA-2 RECEPTOR ANTAGONIST

POTENTIATION OF THE THERAPEUTIC ACTION OF AN OPIOID RECEPTOR AGONIST AND/OR INHIBITION OR REVERSAL OF TOLERANCE TO OPIOID RECEPTOR AGONISTS USING AN ULTRALOW DOSE OF AN ALPHA-2 RECEPTOR ANTAGONIST

机译:使用超低剂量的ALPHA-2受体拮抗剂对阿片受体激动剂的治疗作用进行增强和/或抑制或逆转阿片受体激动剂的耐受性

摘要

Combination therapies of an opioid receptor agonist and an alpha-2 receptor antagonist in an amount effective to potentiate, but not antagonize, a therapeutic effect of the opioid receptor agonist are provided. Also provided are methods for use of these combination therapies in potentiating the therapeutic effects of opioid receptor agonists, inhibiting development of acute and/or chronic tolerance to opioid receptor agonists and treating conditions treatable by opioid receptor agonist therapy in a subject. In addition, a method for reversing opioid receptor agonist tolerance and/or restoring therapeutic effect of an opioid receptor agonist in a subject via administration of an alpha-2 receptor antagonist in an amount effective to potentiate, but not antagonize, the therapeutic effect of the opioid receptor agonist is provided.
机译:提供了有效量的阿片受体激动剂和α-2受体拮抗剂的组合疗法,其有效但不拮抗阿片受体激动剂的治疗效果。还提供了使用这些组合疗法来增强阿片样物质受体激动剂的治疗效果,抑制对阿片样物质受体激动剂的急性和/或慢性耐受的发展以及在受试者中治疗可通过阿片样物质受体激动剂疗法治疗的病症的方法。另外,一种通过以有效增强但不拮抗阿片类药物的治疗效果的量施用α-2受体拮抗剂来逆转阿片样物质受体激动剂耐受性和/或恢复阿片样物质受体激动剂在受试者中的治疗效果的方法。提供了阿片样物质受体激动剂。

著录项

  • 公开/公告号EP1942903A4

    专利类型

  • 公开/公告日2011-01-12

    原文格式PDF

  • 申请/专利权人 QUEENS UNIVERSITY AT KINGSTON;

    申请/专利号EP20060790619

  • 发明设计人 JHAMANDAS KHEM;MILNE BRIAN;

    申请日2006-08-30

  • 分类号A61K31/55;A61K31/137;A61K31/4164;A61K31/4178;A61K31/475;A61K31/48;A61K31/485;A61K31/5415;

  • 国家 EP

  • 入库时间 2022-08-21 17:58:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号